Results 131 to 140 of about 287,515 (190)

Serum CCL18 May Reflect Multiorgan Involvement with Poor Outcome in Systemic Sclerosis. [PDF]

Biomolecules
Filipánits K, Nagy G, Jász DK, Minier T, Simon D, Erdő-Bonyár S, Berki T, Kumánovics G.   +7 more
europepmc   +1 more source

Characterization of the Fecal Metabolome in Patients With Early Systemic Sclerosis. [PDF]

ACR Open Rheumatol
Young AC, Andréasson K, Labus J, Matulionis N, Jacobs JP, Christofk H, Volkmann ER.   +6 more
europepmc   +1 more source

Cellular Players in Gastrointestinal Involvement of Systemic Sclerosis: Insights into Pathogenesis. [PDF]

Cells
Peretti S, Bonomi F, Bandini G, Barbetta C, Hughes M, Del Galdo F, Matucci Cerinic M, McMahan ZH, Bellando Randone S.   +8 more
europepmc   +1 more source

Case-Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease. [PDF]

Arthritis Rheumatol
Goldman N, Ong V, Denton CP.
europepmc   +1 more source

Erratum: Assessment of skin fibrosis in a murine model of systemic sclerosis with multifunctional optical coherence tomography (Erratum). [PDF]

J Biomed Opt
Singh Chawla H, Chen Y, Wu M, Nikitin P, Gutierrez J, Mohan C, Singh M, Aglyamov SR, Assassi S, Larin KV.   +9 more
europepmc   +1 more source

Age and onset timing of Raynaud's phenomenon and first non-Raynaud symptom as prognostic factors in systemic sclerosis: a retrospective analysis from the Italian national multicenter Systemic Sclerosis Progression INvestiGation registry of the Italian Society for Rheumatology (SPRING-SIR). [PDF]

Ther Adv Musculoskelet Dis
Peretti S, Bruni C, Bonomi F, De Angelis R, Bajocchi G, Giuggioli D, Orlandi M, Zanframundo G, Foti R, Visalli E, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Riccieri V, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Cacciapaglia F, Murdaca G, Abignano G, Pettiti G, Della Rossa A, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Idolazzi L, Saracco M, Agnes C, Campochiaro C, De Luca G, Cipolletta E, Fornaro M, Lumetti F, Spinella A, Magnani L, Codullo V, Iandoli C, Gigante A, Pellegrino G, Pigatto E, Lazzaroni MG, De Lorenzis E, Mennillo GA, Battista MD, Pagano Mariano G, Furini F, Vultaggio L, Parisi S, Peroni CL, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Franceschini F, Guiducci S, Dagna L, Doria A, Salvarani C, D'Agostino MA, Iannone F, Matucci-Cerinic M, Ferri C, Randone SB.   +72 more
europepmc   +1 more source

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

, 2020
Bathon, J., Breedveld, F., Burmester, G., Bykerk, V., Crofford, L., Cronstein, B., Dougados, M., Furst, D., Kalden, J., Mariette, X., Mease, P., Melchers, F., Rosenbaum, J., Sieper, J., Smolen, J., Weinblatt, M., Winthrop, K.   +16 more
core   +1 more source

Exploring the anti-fibrotic effects of safflower in systemic sclerosis based on metabolomics and gut microbiota analyses. [PDF]

Front Pharmacol
Zhang Y, Ping X, Wang C, Zhou X, Huang Y, Li K, Lv J.   +6 more
europepmc   +1 more source

Molecular ablation of transforming growth factor beta signaling pathways by tyrosine kinase inhibition: the coming of a promising new era in the treatment of tissue fibrosis. [PDF]

, 2008
Jimenez, Sergio A., Rosenbloom, Joel
core   +1 more source

IL-35 enhances IL-10⁺ breg-mediated immunoregulation and attenuates inflammation and fibrosis in systemic sclerosis. [PDF]

Arthritis Res Ther
Zeng W, Pan D, Lu C, Pan J, Wang X, Huang M, Mo H, Zheng L, Lei L.   +8 more
europepmc   +1 more source